Article
Beyond Carrier Status: CFTR Heterozygosity as an Overlooked Clinical Risk Factor for Pancreatitis.
Clinical genetics - 1 Dec 2025
Richter Lucas D, Ruderfer Douglas M, Peterson Josh F, Bastarache Lisa A
Abstract excerpt
This study assessed the effect of CFTR pathogenic variant status, detected during prenatal carrier screening, for the incidence and clinical recognition of cystic fibrosis-related phenotypes. Data were queried from the Vanderbilt University Medical Center clinical genetic database (CGdb), which includes clinically reported pathogenic variants and electronic health records (EHRs) from 2001 to 2023. Based on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
